Results 191 to 200 of about 28,931 (239)
Some of the next articles are maybe not open access.
Gonadotropin-releasing hormone agonist use before hysterectomy
American Journal of Obstetrics and Gynecology, 1994Our purpose was to compare the effects of leuprolide acetate in patients with symptomatic uterine leiomyoma before hysterectomy.Group I (n = 90) included patients with a pretreatment uterine size of 14 to 18 gestational weeks and group II (n = 60) included patients with uteri > 18 weeks' gestational size.
T G, Stovall +3 more
openaire +2 more sources
Gonadotropin-releasing hormone agonists
Postgraduate Medicine, 1994Use of gonadotropin-releasing hormone (GnRH) agonists produces a transient increase and subsequent long-term reduction in concentrations of pituitary hormones, resulting in gonadal hormone suppression. This reversible suppression is useful in treating diseases dependent on these hormones.
openaire +2 more sources
Uterine ultrasonographic changes with gonadotropin-releasing hormone agonists
American Journal of Obstetrics and Gynecology, 1999Our purpose was to assess the changes in uterine volume and uterine artery pulsatility index in response to gonadotropin-releasing hormone agonist treatment in women undergoing hysterectomy for nonfibroid-related uterine bleeding.A double-blind, placebo-controlled randomized trial of 51 women awaiting hysterectomy in a gynecology outpatient clinic was ...
A D, Weeks, S R, Duffy, J J, Walker
openaire +2 more sources
Depressive symptoms associated with gonadotropin-releasing hormone agonists
Depression and Anxiety, 1998The gonadotropin-releasing hormone (GnRH) agonists are a relatively new class of drugs that are potentially effective in treating disorders that are aggravated either by estrogen or testosterone. GnRH agonists are effective in the treatment of endometriosis, as well as other disorders, such as advanced prostrate cancer, precocious puberty and uterine ...
J K, Warnock, J C, Bundren, D W, Morris
openaire +2 more sources
Gonadotropin-Releasing Hormone: Agonists and Antagonists
1997In adult women the cyclic function of the ovaries is embedded in the hypothalamic, pituitary, and ovarian feedback mechanisms [1]. The hypothalamus is the superordinate organ releasing gonadotropin-releasing hormone (GnRH) in a pulsatile manner. GnRH is secreted by the neural cells of the nucleus arcuatus in the mediobasal portion of the hypothalamus ...
R. Felberbaum, T. Rabe, K. Diedrich
openaire +1 more source
Treatment of Prostate Cancer with Gonadotropin-Releasing Hormone Agonists
Endocrine Reviews, 1986It is now well established that chronic treatment with GnRH agonists offers an advantageous alternative to orchiectomy and estrogens for the treatment of prostate cancer. Castration levels of androgens can thus be easily achieved without side effects other than those related to castration levels of serum androgens.
F, Labrie +7 more
openaire +2 more sources
The effects of a gonadotropin-releasing hormone agonist on testicular histology
Fertility and Sterility, 1987We have described the histologic changes in the testes of men treated with buserelin for prostatic cancer. If these changes are reversible, then the agonist analogues, together with testosterone replacement therapy, could be used safely for male contraception.
J, Waxman +4 more
openaire +2 more sources
Journal of Animal Science, 1988
Sexually mature gilts (n = 20) were actively immunized against GnRH. Primary and booster immunizations of GnRH conjugated to bovine serum albumin induced production of antibodies in all gilts. Nineteen of the gilts became acyclic with suppressed concentrations of gonadotropins and estradiol.
G B, Traywick, K L, Esbenshade
openaire +2 more sources
Sexually mature gilts (n = 20) were actively immunized against GnRH. Primary and booster immunizations of GnRH conjugated to bovine serum albumin induced production of antibodies in all gilts. Nineteen of the gilts became acyclic with suppressed concentrations of gonadotropins and estradiol.
G B, Traywick, K L, Esbenshade
openaire +2 more sources
Gonadotropin-releasing hormone agonist (GnRH-A) in hirsutism.
Acta Europaea fertilitatis, 1995Twenty-five women presenting moderate-severe PCOS-dependant hirsuitism were treated for 6 months with GnRH-A (Group A) or pill-combined and GnRH (Group B). Both therapeutic regimens significantly decreased androgen plasma levels. Hair diameter reduced in Group A by 22-34% and in Group B by 25-35%, while hirsuitism score respectively decreased by 22 and
L, Falsetti, E, Pasinetti, D, Ceruti
openaire +2 more sources
Gonadotropin-Releasing Hormone Agonist Treatment in Sexual Precocity
2015Depot gonadotropin-releasing hormone (GnRH) analogs represent the first-line therapy in sexual precocity due to central precocious puberty. GnRH analogs desensitize the pituitary and account for the suppression of luteinizing hormone and follicle-stimulating hormone leading to a decrease of sex steroid levels.
Catherine, Pienkowski, Maithé, Tauber
openaire +2 more sources